Overview

Erythropoietin Therapy for Children With Cerebral Palsy

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This randomized placebo-controlled trial aims to investigate the efficacy and safety of erythropoetin for children with cerebral palsy.
Phase:
Phase 2
Details
Lead Sponsor:
Bundang CHA Hospital
Collaborator:
LG Life Sciences
Treatments:
Epoetin Alfa